These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 5272106)
21. [Treatment of Parkinson's syndrome with L-dopa]. Ljung O Lakartidningen; 1972 Jun; 69(24):2940-4. PubMed ID: 5037135 [No Abstract] [Full Text] [Related]
22. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease]. Buscaino GA; Campanella G Sist Nerv; 1970; 22(2):82-91. PubMed ID: 5504561 [No Abstract] [Full Text] [Related]
23. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease. Van Woert MH Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103 [No Abstract] [Full Text] [Related]
24. Parkinson's disease treated with L-dopa. Three-year follow-up report. Mones RJ N Y State J Med; 1972 Nov; 72(22):2749-50. PubMed ID: 4510706 [No Abstract] [Full Text] [Related]
25. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases]. Pimenta Ada M; Friguglietti DJ Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650 [No Abstract] [Full Text] [Related]
26. [Levo-dopa in the treatment of Parkinson's disease]. Fasano VA; Urciuoli R; Broggi G; Cannella M Minerva Med; 1969 Nov; 60(95):4733-45. PubMed ID: 5357313 [No Abstract] [Full Text] [Related]
27. Quantitative measurements of L-dopa therapy in Parkinson's disease. Webster DD Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483 [No Abstract] [Full Text] [Related]
28. L-dopa and the patient with Parkinson's disease. Fangman A; O'Malley WE Am J Nurs; 1969 Jul; 69(7):1455-7. PubMed ID: 5192672 [No Abstract] [Full Text] [Related]
29. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy. Lipman IJ; Papadopoulos NM Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194 [No Abstract] [Full Text] [Related]
30. Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease. Greer M; Anton AH Trans Am Neurol Assoc; 1970; 95():247-8. PubMed ID: 4328099 [No Abstract] [Full Text] [Related]
31. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)]. Mazza C; Buffatti PF; Bazzan A; Lion P Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378 [No Abstract] [Full Text] [Related]
32. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease. Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950 [No Abstract] [Full Text] [Related]
33. [Results of L-dopa treatment in 117 patients with Parkinson's disease followed for 1 year or more]. Bonduelle M; Bouygues P; Lormeau G; de Maricourt C Rev Neurol (Paris); 1972 Aug; 127(2):309-11. PubMed ID: 4666637 [No Abstract] [Full Text] [Related]
34. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method]. Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721 [No Abstract] [Full Text] [Related]
39. [Study of 30 parkinsonian patients treated for 6 months with L-Dopa]. Barbizet J; Duizabo P Therapie; 1972; 27(1):133-40. PubMed ID: 5017549 [No Abstract] [Full Text] [Related]
40. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia]. Serrano PA; Irigoyen M Prensa Med Mex; 1972; 37(7):246-50. PubMed ID: 4646433 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]